Naseema Gangat, MBBS

Naseema Gangat, MBBS, is a Mayo Clinic hematologist and professor of medicine. Board certified in oncology, hematology, and internal medicine, she focuses on myeloid malignancies and has published 100+ works while mentoring trainees and leading research, teaching, and curriculum efforts.

Articles by Naseema Gangat, MBBS

Controversies in CML and MPNs

Naval Daver, MDChronic Myeloid Leukemia | June 5, 2025

Expert insights from a HemOnc Pulse Live! session offer a compelling look at where CML and MPN care is headed.

Patient-Centered Approaches in Today’s MF Treatment Paradigm

Pankit Vachhani, MDMyelofibrosis | May 12, 2025

Experts discuss patient-centered approaches and novel therapies reshaping MF treatment in a roundtable.

Future-Ready MF Care: Better Outcomes Through Research

Prithviraj Bose, MDMyelofibrosis | May 12, 2025

Experts explore anemia therapies, JAK inhibitors, and transplant innovations shaping the promising future of MF care.

Tailoring Myelofibrosis Care With the Latest Molecular Discoveries

Naseema Gangat, MBBSMyelofibrosis | May 12, 2025

Experts discuss molecular insights into MF, highlighting mutations, risk assessment, and evolving therapeutic approaches.

The Evolving Role of Targeted Therapy in Myelofibrosis

Prithviraj Bose, MDMyelofibrosis | May 12, 2025

Experts discuss current treatments and ongoing research in myelofibrosis, highlighting new therapies and clinical trials.

Tomorrow’s Myelofibrosis Therapies

Idoroenyi Amanam, MDMyelofibrosis | May 12, 2025

Experts discuss CALR-targeting therapies, symptom assessment, and the future of myelofibrosis treatment and regulation.